Nalaganje...
Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Methods. We conducted a retrospective cohort study of IBD patients who were prescribed anti-TNF therapy (2007–2014) in Ontario. We assessed if the insurance type...
Shranjeno v:
| izdano v: | Can J Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5292380/ https://ncbi.nlm.nih.gov/pubmed/28239601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7365937 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|